1XJ1

3D solution structure of the C-terminal cysteine-rich domain of the VHv1.1 polydnaviral gene product

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D TOCSY	1mM C-term VHv1.1, 25mM sodium phosphate, 100mM NaCl, 1mM EDTA, 0.01% sodium azide	95% H2O/5% D2O	100mM NaCl	5.7	ambient	315
2	2D NOESY	1mM C-term VHv1.1, 25mM sodium phosphate, 100mM NaCl, 1mM EDTA, 0.01% sodium azide	95% H2O/5% D2O	100mM NaCl	5.7	ambient	315
3	DQF-COSY	1mM C-term VHv1.1, 25mM sodium phosphate, 100mM NaCl, 1mM EDTA, 0.01% sodium azide	95% H2O/5% D2O	100mM NaCl	5.7	ambient	315

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX	600

NMR Refinement
Method	Details	Software
torsion angle dynamics and simulated annealing protocols using CNS	The structures are based on 280 NOE-derived interproton distance constraints, 24 distance restraints from 12 hydrogen bonds	XWINNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	25
Conformers Submitted Total Number	25
Representative Model	17 (lowest energy)

Additional NMR Experimental Information
Details	This ensemble of NMR structures was determined using standard 2D 1H homonuclear NMR techniques

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	XWINNMR	2.6	Bruker
2	structure solution	CNS	1.0	Brunger
3	refinement	CNS	1.0	Brunger

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.